JP Morgan Chase
CARM

JP Morgan Chase’s Carisma Therapeutics CARM Stock Holding History

JP Morgan Chase’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-921
Closed -$252 – 7463
2025
Q3 		$252 Hold
921
– – ﹤0.01% 7097
2025
Q2 		$361 Sell
921
-27
-3% -$7 ﹤0.01% 6731
2025
Q1 		$294 Buy
948
+27
+3% +$12 ﹤0.01% 6755
2024
Q4 		$386 Hold
921
– – ﹤0.01% 6830
2024
Q3 		$904 Hold
921
– – ﹤0.01% 6734
2024
Q2 		$1.4K Sell
921
-10,760
-92% -$16.1K ﹤0.01% 6572
2024
Q1 		$26.5K Sell
11,681
-5,893
-34% -$14.2K ﹤0.01% 6149
2023
Q4 		$51.5K Hold
17,574
– – ﹤0.01% 5990
2023
Q3 		$74.3K Sell
17,574
-3,390
-16% -$21.5K ﹤0.01% 5649
2023
Q2 		$184K Buy
20,964
+20,673
+7,104% +$113K ﹤0.01% 5122
2023
Q1 		$1K Hold
291
– – ﹤0.01% 6499
2022
Q4 		$4K Sell
291
-399
-58% -$4.19K ﹤0.01% 6189
2022
Q3 		$6K Buy
690
+234
+51% +$3.19K ﹤0.01% 6052
2022
Q2 		$7K Sell
456
-5,453
-92% -$62.4K ﹤0.01% 6094
2022
Q1 		$71K Buy
5,909
+1,228
+26% +$17.2K ﹤0.01% 5650
2021
Q4 		$77K Buy
4,681
+879
+23% +$17.7K ﹤0.01% 5778
2021
Q3 		$60K Buy
3,802
+520
+16% +$25K ﹤0.01% 5771
2021
Q2 		$303K Buy
+3,282
New +$209K ﹤0.01% 5011
2015
Q2 		– Sell
-14,895
Closed -$2.66M – 4028
2015
Q1 		$2.66M Sell
14,895
-3,334
-18% -$728K ﹤0.01% 2733
2014
Q4 		$4.33M Sell
18,229
-1,456
-7% -$327K ﹤0.01% 2494
2014
Q3 		$4.38M Buy
19,685
+7,012
+55% +$1.67M ﹤0.01% 2449
2014
Q2 		$3.34M Sell
12,673
-3,071
-20% -$760K ﹤0.01% 2275
2014
Q1 		$5.11M Buy
+15,744
New +$4.72M ﹤0.01% 2072

Other funds holding CARM

MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OP
ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return

JP Morgan Chase's CARM Position: Q4 2025 in Review

JP Morgan Chase sold out of Carisma Therapeutics (CARM) in Q4 2025, closing a stake of 921 shares — an estimated $252 sold.

JP Morgan Chase first reported a position in CARM in Q1 2014 and held it in 23 quarters. The position peaked at $5.11M in Q1 2014. 7 funds tracked by Wall St. Rank hold CARM as of Q4 2025.

  • JP Morgan Chase reported no remaining Carisma Therapeutics position as of Q4 2025 after selling out during the quarter.
  • JP Morgan Chase sold 921 Carisma Therapeutics shares in Q4 2025, an estimated $252.
  • JP Morgan Chase first reported a position in Carisma Therapeutics in Q1 2014 and held it in 23 quarters.
  • JP Morgan Chase's Carisma Therapeutics position peaked at $5.11M in Q1 2014.
  • 7 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2025.

Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.